Health Company Announces Out-License Deal With Bioscience Firm For Schizophrenia Drug Candidate
Jaguar Health Executes Out-License Deal with Joint Venture Magdalena Biosciences for Botanical Drug Candidate for Schizophrenia.
Disclaimer: The information provided in this article is for informational purposes only and does not constitute investment advice, medical advice, or any other form of professional consultation. The data and statements about Jaguar Health, Magdalena Biosciences, and their drug candidate are based on publicly available information…